A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction.
第一作者:
Thor,Ostenfeld
第一单位:
Neurology Discovery Medicine Unit, GlaxoSmithKline R&D, Harlow, UK. thor.x.ostenfeld@gsk.com
作者:
医学主题词
青少年(Adolescent);成年人(Adult);镇痛药, 非麻醉(Analgesics, Non-Narcotic);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);布洛芬(Ibuprofen);男(雄)性(Male);中年人(Middle Aged);磨牙, 第三(Molar, Third);疼痛测定(Pain Measurement);疼痛, 手术后(Pain, Postoperative);吡喃类(Pyrans);嘧啶类(Pyrimidines);受体, 大麻酚, CB2(Receptor, Cannabinoid, CB2);回顾性研究(Retrospective Studies);拔牙(Tooth Extraction);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1097/AJP.0b013e318219799a
PMID
21540741
发布时间
2022-03-17
- 浏览33
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



